121 related articles for article (PubMed ID: 32680777)
1. Risk Factors for Cancer-specific Mortality and Cardiovascular Mortality in Patients With Diffuse Large B-cell Lymphoma.
Zhao J; Su L; Zhong J
Clin Lymphoma Myeloma Leuk; 2020 Nov; 20(11):e858-e863. PubMed ID: 32680777
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtype.
Abuamsha H; Kadri AN; Hernandez AV
Hematol Oncol; 2019 Aug; 37(3):261-269. PubMed ID: 30916804
[TBL] [Abstract][Full Text] [Related]
3. Competing risk analysis of cardiovascular/cerebrovascular death in T1/2 kidney cancer: a SEER database analysis.
Mo X; Zhou M; Yan H; Chen X; Wang Y
BMC Cancer; 2021 Jan; 21(1):13. PubMed ID: 33402111
[TBL] [Abstract][Full Text] [Related]
4. Racial differences in treatment and survival in older patients with diffuse large B-cell lymphoma (DLBCL).
Griffiths R; Gleeson M; Knopf K; Danese M
BMC Cancer; 2010 Nov; 10():625. PubMed ID: 21073707
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular diseases among diffuse large B-cell lymphoma long-term survivors in Asia: a multistate model study.
Lee SF; Vellayappan BA; Wong LC; Chiang CL; Chan SK; Wan EY; Wong IC; Lambert PC; Rachet B; Ng AK; Luque-Fernandez MA
ESMO Open; 2022 Feb; 7(1):100363. PubMed ID: 35026723
[TBL] [Abstract][Full Text] [Related]
6. Associations between race and survival in pediatric patients with diffuse large B-cell lymphoma.
Khullar K; Plascak JJ; Drachtman R; Cole PD; Parikh RR
Cancer Med; 2021 Feb; 10(4):1327-1334. PubMed ID: 33503323
[TBL] [Abstract][Full Text] [Related]
7. Primary Thyroid Lymphoma: An Analysis of the National Cancer Database.
Vardell Noble V; Ermann DA; Griffin EK; Silberstein PT
Cureus; 2019 Feb; 11(2):e4088. PubMed ID: 31057992
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Indicators of Survival in Sinonasal Diffuse Large B-Cell Lymphoma: A National Cancer Database Analysis.
Brown HJ; Varelas EA; Ganti A; Papagiannopoulos P; Mark M; Kuan EC; Tajudeen BA
Laryngoscope; 2022 Aug; 132(8):1515-1522. PubMed ID: 34542177
[TBL] [Abstract][Full Text] [Related]
9. Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: an analysis of the Surveillance, Epidemiology and End Results database.
Castillo JJ; Winer ES; Olszewski AJ
Am J Hematol; 2014 Mar; 89(3):310-4. PubMed ID: 24273125
[TBL] [Abstract][Full Text] [Related]
10. Cancer-specific mortality, cure fraction, and noncancer causes of death among diffuse large B-cell lymphoma patients in the immunochemotherapy era.
Howlader N; Mariotto AB; Besson C; Suneja G; Robien K; Younes N; Engels EA
Cancer; 2017 Sep; 123(17):3326-3334. PubMed ID: 28464214
[TBL] [Abstract][Full Text] [Related]
11. Site-Specific Survival of Extra Nodal Diffuse Large B-Cell Lymphoma and Comparison With Gastrointestinal Diffuse Large B-Cell Lymphoma.
Gupta V; Singh V; Bajwa R; Meghal T; Sen S; Greenberg D; Anne M; Levitt MJ
J Hematol; 2022 Apr; 11(2):45-54. PubMed ID: 35573751
[TBL] [Abstract][Full Text] [Related]
12. New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study.
Cai QQ; Hu LY; Geng QR; Chen J; Lu ZH; Rao HL; Liu Q; Jiang WQ; Huang HQ; Lin TY; Xia ZJ
Chin J Cancer; 2016 Sep; 35(1):87. PubMed ID: 27624700
[TBL] [Abstract][Full Text] [Related]
13. Association of Disease Location and Treatment With Survival in Diffuse Large B-Cell Lymphoma of the Eye and Ocular Adnexal Region.
Ahmed AH; Foster CS; Shields CL
JAMA Ophthalmol; 2017 Oct; 135(10):1062-1068. PubMed ID: 28880986
[TBL] [Abstract][Full Text] [Related]
14. Comparative effectiveness and cost of adding rituximab to first-line chemotherapy for elderly patients diagnosed with diffuse large B-cell lymphoma.
Griffiths RI; Gleeson ML; Mikhael J; Dreyling MH; Danese MD
Cancer; 2012 Dec; 118(24):6079-88. PubMed ID: 22648454
[TBL] [Abstract][Full Text] [Related]
15. Causes of death and effect of non-cancer-specific death on rates of overall survival in adult classic Hodgkin lymphoma: a populated-based competing risk analysis.
Gao J; Chen Y; Wu P; Wang F; Tao H; Shen Q; Wang S; Gong S; Zhang X; Zhou Z; Song X; Jia Y
BMC Cancer; 2021 Aug; 21(1):955. PubMed ID: 34433456
[TBL] [Abstract][Full Text] [Related]
16. Outcomes and effect of radiotherapy in patients with stage I or II diffuse large B-cell lymphoma: a surveillance, epidemiology, and end results analysis.
Ballonoff A; Rusthoven KE; Schwer A; McCammon R; Kavanagh B; Bassetti M; Newman F; Rabinovitch R
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1465-71. PubMed ID: 18495371
[TBL] [Abstract][Full Text] [Related]
17. Presence of a high-grade component in gastric mucosa-associated lymphoid tissue (MALT) lymphoma is not associated with an adverse prognosis.
Ang MK; Hee SW; Quek R; Yap SP; Loong S; Tan L; Tao M; Lim ST
Ann Hematol; 2009 May; 88(5):417-24. PubMed ID: 18777110
[TBL] [Abstract][Full Text] [Related]
18. [Different treatment regimens for primary central nervous system lymphoma:based on SEER database].
Yang CW; Ren XH; Jiang HH; Li MX; Zhao XZ; Zhu QH; Cui Y; Lin S
Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):52-58. PubMed ID: 33412634
[No Abstract] [Full Text] [Related]
19. Insurance status is related to diffuse large B-cell lymphoma survival.
Han X; Jemal A; Flowers CR; Sineshaw H; Nastoupil LJ; Ward E
Cancer; 2014 Apr; 120(8):1220-7. PubMed ID: 24474436
[TBL] [Abstract][Full Text] [Related]
20. Trends in Survival of Patients with Primary Gastric Diffuse Large B-Cell Lymphoma: An Analysis of 7051 Cases in the SEER Database.
Liu PP; Xia Y; Bi XW; Wang Y; Sun P; Yang H; Li ZM; Jiang WQ
Dis Markers; 2018; 2018():7473935. PubMed ID: 30410635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
